ELI Lilly and Co (LLY) Sentiment & Fear and Greed Index
As of July 5, 2026, ELI Lilly and Co's Ruma Fear & Greed Index is 0 (Extreme Fear), it holds 0.00% of crypto social mindshare. These signals are computed by Ruma from social posts across crypto Twitter/X and other sources, scored with large language models rather than keyword counts.
Updated continuously · Source: Ruma
Latest ELI Lilly and Co insights
Biotechnology giant Eli Lilly has invested a substantial $300 million into the $BIO crypto protocol. This investment is particularly noteworthy as $BIO's market capitalization previously stood at just over $100 million. The capital injection represents a significant commitment from a traditional biotech firm into a crypto project.
Pharmaceutical giant Eli Lilly has acquired Crossbridge Bio for $300 million. This acquisition involves a drug candidate that was previously funded through the VitaDAO ecosystem. The deal marks a significant milestone, representing the first nine-figure pharmaceutical acquisition of intellectual property developed via a decentralized autonomous organization (DAO) ecosystem.
Frequently asked questions
What is ELI Lilly and Co's Fear & Greed Index?
ELI Lilly and Co's Ruma Fear & Greed Index is currently 0 out of 100, which is Extreme Fear. The index blends social sentiment, social interest, price momentum, volatility, and emotional intensity into a single 0–100 sentiment score, updated continuously.
Is ELI Lilly and Co bullish or bearish right now?
Ruma scores ELI Lilly and Co's social sentiment as bullish, bearish, or mixed based on LLM analysis of the crypto social conversation. Sentiment reflects market mood, not financial advice.
How does Ruma measure ELI Lilly and Co sentiment?
Ruma reads every relevant social post about ELI Lilly and Co across crypto Twitter/X and other sources and scores it with large language models — capturing bullish/bearish tone, emotion, and who is speaking (from retail to smart money) — rather than counting keywords.